002004.SZ
华邦健康
SZSE · Basic Materials · C 制造业 · CN
CNY 4.47
−0.67%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 11.5B | 11.5B | 11.7B | 11.6B | 13.2B |
| Cost of Revenue | 7.3B | 7.3B | 7.7B | 7.1B | 7.9B |
| Gross Profit | 4.2B | 4.3B | 4.0B | 4.5B | 5.4B |
| Operating Expenses | |||||
| R&D Expense | 310.8M | 341.6M | 375.3M | 419.1M | 385.2M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 1.2B | 1.2B | 1.3B | 1.3B | 1.5B |
| Selling & Marketing Expense | 1.1B | 1.1B | 1.0B | 1.3B | 1.5B |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 3.0B | 3.1B | 3.1B | 3.4B | 3.7B |
| Cost and Expenses | 10.3B | 10.4B | 10.8B | 10.4B | 11.6B |
| Operating Income (EBIT) | 1.1B | 1.0B | (127.4M) | 926.5M | 1.6B |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 1.1B | 1.1B | (160.5M) | 892.4M | 1.6B |
| Income Tax Expense | 187.8M | 176.6M | 182.1M | 215.5M | 495.5M |
| Bottom Line | |||||
| Net Income | 683.7M | 713.2M | (299.0M) | 302.1M | 433.5M |
| Earnings from Cont. Ops | 881.3M | 881.2M | (342.6M) | 676.9M | 1.1B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 683.7M | 713.2M | (299.0M) | 302.1M | 433.5M |
| Per Share | |||||
| Basic EPS | CN¥0.35 | CN¥0.36 | (CN¥0.15) | CN¥0.15 | CN¥0.22 |
| Diluted EPS | CN¥0.35 | CN¥0.36 | (CN¥0.15) | CN¥0.15 | CN¥0.22 |
| Revenue Per Share | CN¥5.84 | CN¥5.84 | CN¥5.91 | CN¥5.86 | CN¥6.68 |
| Shares | |||||
| Basic Shares Outstanding | 2.0B | 2.0B | 2.0B | 2.0B | 2.0B |
| Diluted Shares Outstanding | 2.0B | 2.0B | 2.0B | 2.0B | 2.0B |
| Profitability Metrics | |||||
| EBITDA | — | 2.2B | 894.0M | 1.9B | 2.5B |
| D&A | — | 1.1B | 1.0B | 945.6M | 859.0M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026